Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hypoestes rosea Herbal Supplement is an herbal product composed of powdered dried leaves from the *Hypoestes rosea* shrub, a plant native to Nigeria. Developed by Immune Modulation, Inc. (also known as IMI Pharma), the supplement is currently in preclinical development for the prevention and management of colon polyps, inflammation, diabetes, and high cholesterol. Unlike the company's primary drug candidate, Hypoestoxide (a purified diterpene isolated from the same plant), this supplement utilizes the whole plant material. No specific molecular mechanism of action has been defined for the product, which is classified as an herbal supplement rather than a purified pharmaceutical compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hypoestes rosea Herbal Supplement.